Table 1 Baseline characteristics of patients according to the severity of carotid atherosclerosis
Mild group | Moderate group | Severe group | F value/χ2 p | |
|---|---|---|---|---|
(n = 87) | (n = 105) | (n = 64) | ||
Gender (M/F) | 55/32 | 64/44 | 40/24 | 0.653 > 0.05 |
Age (years) | 75.52 ± 3.32 | 76.21 ± 7.21 | 76.01 ± 5.21 | 0.487 > 0.05 |
DM duration (years) | 23.89 ± 2.32 | 23.28 ± 1.26 | 24.79 ± 3.43 | 0.563 > 0.05 |
BMI (kg/m2) | 25.13 ± 2.54 | 26.40 ± 5.24 | 28.24 ± 5.14* | 8.324 < 0.05 |
WHR | 0.83 ± 0.13 | 0.86 ± 0.24 | 0.98 ± 0.65*△ | 11.324 < 0.01 |
SBP (mmHg) | 135 ± 6 | 141 ± 13 | 148 ± 12* | 4.213 < 0.05 |
DBP (mmHg) | 69 ± 4 | 67 ± 7 | 72 ± 9 | 0.672 > 0.05 |
Medications, n (%) | ||||
Aspirin | 26 (29.8%) | 54 (51.4%) | 48 (75%) | 6.324 < 0.05 |
Statins | 34 (39%) | 55 (52%) | 50 (78.1%) | 7.324 < 0.01 |
Probucol | 10 (11.4%) | 25 (23.8%) | 40 (62.5%) | 5.234 < 0.05 |
Metformin | 35 (40.2%) | 74 (70.4%) | 55 (85.9%) | 5.341 < 0.05 |
Acarbose | 55 (63.2%) | 76 (72.3%) | 55 (85.9%) | 0.985 > 0.05 |
SUs | 15 (17.2%) | 27 (25.7%) | 16 (17.8%) | 0.765 > 0.05 |
TZDs | 35 (40.2%) | 57 (54.2%) | 48 (75%) | 2.543 < 0.05 |
Insulin | 22 (25.2%) | 46 (43.8%) | 45 (70.3%) | 4.324 < 0.05 |